$CVS Income Statement | Understand Stock

$CVS

$92.53 -$0.94 (1.01%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues:
Revenues
Products
Services
Premiums
Net investment income
Total revenues
Operating costs:
Cost of products sold
Health care costs
Operating expenses
Goodwill impairment
Restructuring charges
Opioid litigation charges
Loss on assets held for sale
Store impairments
Total operating costs
Operating income
Interest expense
Gain on early extinguishment of debt
Other income
Income before income tax provision
Income tax provision
Income from continuing operations
Loss from discontinued operations, net of tax
Net income
Net (income) loss attributable to noncontrolling interests
Net income attributable to CVS Health
Income from continuing operations attributable to CVS Health (in dollars per share)
Loss from discontinued operations attributable to CVS Health (in dollars per share)
Net income per share attributable to CVS Health:
Basic (in dollars per share)
Diluted (in dollars per share)
Weighted average shares outstanding:
Basic (in shares)
Income from continuing operations attributable to CVS Health (in dollars per share)
Loss from discontinued operations attributable to CVS Health (in dollars per share)
Diluted (in shares)

Dividends declared per share (in dollars per share)

Comments